Prostate Adenocarcinoma: Clinical Trials

6 trials for Prostate Adenocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Terminated 6
Phase 23Terminated 3

Follow Prostate Adenocarcinoma: new trials by email Literature Review of Prostate Adenocarcinoma trials Research Report on Prostate Adenocarcinoma

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients
Relugolix Pill, Ritonavir, Itraconazole - Prostate Cancer, Prostate Cancer Metastatic
Phase 1TerminatedUniversity of Chicago602023-02-132024-09-19
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.
Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log - Prostate Cancer, Prostate Adenocarcinoma
Phase 1TerminatedUniversity of Chicago502023-01-242025-10-03
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
Talazoparib, Temozolomide - Prostate Cancer, Prostate Adenocarcinoma
Phase 1 / Phase 2TerminatedMemorial Sloan Kettering Cancer Center162019-07-112026-08-24
Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
Entinostat, Enzalutamide - Prostate Adenocarcinoma
Phase 1TerminatedGeorge Washington University62019-05-012021-08-02
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
Goserelin Acetate, Laboratory Biomarker Analysis, Leuprolide Acetate - Prostate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v7
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)102010-07-092019-02-28
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
Calcitriol, Ketoconazole, Laboratory Biomarker Analysis - Prostate Adenocarcinoma, Recurrent Prostate Carcinoma
Phase 1 / Phase 2TerminatedRoswell Park Cancer Institute512006-10-012017-06-14

Narrower conditions

Prostatic Neoplasms (5)

Broader conditions

Genital Diseases (5)  ·  Genital Diseases, Male (5)  ·  Genital Neoplasms, Male (5)  ·  Male Urogenital Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Prostatic Diseases (5)  ·  Urogenital Diseases (5)  ·  Urogenital Neoplasms (5)

Interventions

Abiraterone Acetate (1)  ·  Calcitriol (1)  ·  Goserelin (1)  ·  HhAntag691 (1)  ·  Hydrocortisone (1)  ·  Itraconazole (1)  ·  Ketoconazole (1)  ·  Leuprolide (1)  ·  Prednisone (1)  ·  Ritonavir (1)  ·  Temozolomide (1)  ·  abiraterone (1)  ·  entinostat (1)  ·  enzalutamide (1)  ·  luprolide acetate gel depot (1)

Sponsors

University of Chicago (2)  ·  George Washington University (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (6)

Top investigators

Christopher Logothetis (1)  ·  Jianquig Lin, MD (1)  ·  Karen Autio, MD (1)  ·  Russell Szmulewitz, MD (1)  ·  Saby George (1)  ·  Walter Stadler (1)

Results publications

PMID 20818327, PMID 40906325

NIH funding

N01CM00039 (1), N01CM62202 (1), P30CA016056 (1), P30CA016672 (1), U01CA062461 (1), U01CA062491 (1)